FMP
Oct 21, 2024 5:08 PM - Alex Lavoie
Image credit: Google Images
On October 21, 2024, Cantor Fitzgerald maintained its "Overweight" rating for CVRx, Inc. (NASDAQ: CVRX), a company specializing in medical devices. The stock was held at a price of $10.55. CVRx focuses on innovative therapies for heart failure, with its flagship product being Barostim, a baroreflex activation therapy.
Recently, CVRx announced that the American Medical Association (AMA) approved new CPT Category I codes for Barostim. This approval is significant as it acknowledges the therapy's growing use and positive clinical outcomes. The new codes, effective January 1, 2026, will likely improve reimbursement processes for healthcare providers, broadening patient access to Barostim.
The stock price of CVRX has seen a notable increase, currently trading at $10.91, up by 14.96% or $1.42. This rise reflects investor optimism following the AMA's approval. The stock has fluctuated today between $9.65 and $11.03, indicating active trading interest.
CVRx's market capitalization is approximately $237.68 million, with a trading volume of 583,553 shares. Over the past year, the stock has experienced a high of $33.14 and a low of $6.40. This volatility highlights the market's response to the company's developments and potential growth prospects.
May 14, 2024 11:41 AM - Sanzhi Kobzhan
A stock's target price, also known as its fair value, is an indication of what a share can cost based on the company’s forecasted financial statements. It is important to know a stock's fair value to find undervalued stocks with great growth potential. Let's consider how investment analysts calculat...
May 16, 2024 8:06 PM - Gordon Thompson
On Thursday, May 16, 2024, Deutsche Bank upgraded its rating on NASDAQ:ASTS to Buy, maintaining a hold position. At the time of the announcement, ASTS was trading at $4.03. This decision was accompanied by an increase in the price target for AST SpaceMobile, raised to $22 from $19, as detailed in a ...
May 24, 2024 9:30 AM - Rajnish Katharotiya
Earnings call transcripts are invaluable resources for investors, analysts, and financial enthusiasts. They provide insights into a company's performance, strategy, and future outlook, making them essential for making informed investment decisions. With Financial Modeling Prep, Earnings Call Transcr...